NO911749L - Bis-arylamid og urea-antagonister for blodplateaktiverende faktor. - Google Patents
Bis-arylamid og urea-antagonister for blodplateaktiverende faktor.Info
- Publication number
- NO911749L NO911749L NO91911749A NO911749A NO911749L NO 911749 L NO911749 L NO 911749L NO 91911749 A NO91911749 A NO 91911749A NO 911749 A NO911749 A NO 911749A NO 911749 L NO911749 L NO 911749L
- Authority
- NO
- Norway
- Prior art keywords
- arylamide
- bis
- activating factor
- blood plate
- antagonists
- Prior art date
Links
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title 1
- 230000003213 activating effect Effects 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 239000004202 carbamide Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
- C07D213/20—Quaternary compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D277/28—Radicals substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US07/519,525 US5128351A (en) | 1990-05-04 | 1990-05-04 | Bis-aryl amide and urea antagonists of platelet activating factor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO911749D0 NO911749D0 (no) | 1991-05-03 |
| NO911749L true NO911749L (no) | 1991-11-05 |
Family
ID=24068683
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO91911749A NO911749L (no) | 1990-05-04 | 1991-05-03 | Bis-arylamid og urea-antagonister for blodplateaktiverende faktor. |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US5128351A (fr) |
| EP (1) | EP0458037A1 (fr) |
| JP (1) | JPH061765A (fr) |
| KR (1) | KR910019989A (fr) |
| CN (1) | CN1056494A (fr) |
| AU (1) | AU639325B2 (fr) |
| CA (1) | CA2041687A1 (fr) |
| FI (1) | FI912143A7 (fr) |
| HU (1) | HUT60720A (fr) |
| IE (1) | IE911512A1 (fr) |
| IL (1) | IL97790A0 (fr) |
| NO (1) | NO911749L (fr) |
| PH (1) | PH27535A (fr) |
| PL (1) | PL290120A1 (fr) |
| PT (1) | PT97538A (fr) |
| ZA (1) | ZA913365B (fr) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5231091A (en) * | 1988-12-19 | 1993-07-27 | American Cyanamid Company | Bis-arylphosphate ester antagonists of platelet activating factor |
| CA2014880A1 (fr) * | 1989-04-27 | 1990-10-27 | Indu Sawhney | Derives du thiazole |
| WO1997024343A1 (fr) | 1995-12-29 | 1997-07-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | Derives de phenylthiazole dotes de proprietes anti virus de l'herpes |
| US6288091B1 (en) | 1995-12-29 | 2001-09-11 | Boehringer Ingelheim Ltd. | Antiherpes virus compounds and methods for their preparation and use |
| NZ328607A (en) * | 1996-09-09 | 1999-08-30 | Hoffmann La Roche | Heterocyclically substituted n-benzyl-azolium derivatives and fungicidal compositions |
| WO2000006550A1 (fr) | 1998-07-31 | 2000-02-10 | Nippon Soda Co., Ltd. | Composes phenylazole, procede de production desdits composes et medicaments pour le traitement de l'hyperlipidemie |
| US6121300A (en) | 1998-11-10 | 2000-09-19 | Wagle; Dilip R. | Reversing advanced glycosylation cross-links using heterocyclic-substituted thiazolium salts |
| US7272192B2 (en) * | 2000-04-14 | 2007-09-18 | Board Of Trustees Of The Leland Stanford Junior University | Time-reversal block transmit diversity system for channels with intersymbol interference and method |
| WO2003042190A1 (fr) * | 2001-11-12 | 2003-05-22 | Pfizer Products Inc. | Derives de n-adamantylalkyle benzamide en tant qu'antagonistes du recepteur p2x7 |
| PA8557501A1 (es) | 2001-11-12 | 2003-06-30 | Pfizer Prod Inc | Benzamida, heteroarilamida y amidas inversas |
| WO2004058722A1 (fr) * | 2002-12-24 | 2004-07-15 | Arena Pharmaceuticals, Inc. | Derives du pyrazole diarylamine et du pyrazole arylheteroarylamine modulateurs du 5ht2a |
| PA8591801A1 (es) * | 2002-12-31 | 2004-07-26 | Pfizer Prod Inc | Inhibidores benzamidicos del receptor p2x7. |
| US7071223B1 (en) | 2002-12-31 | 2006-07-04 | Pfizer, Inc. | Benzamide inhibitors of the P2X7 receptor |
| WO2004092153A1 (fr) | 2003-04-14 | 2004-10-28 | Nippon Soda Co. Ltd. | Derive diamine, procede de production et medicament antioxydant |
| ATE355273T1 (de) * | 2003-05-12 | 2006-03-15 | Pfizer Prod Inc | Benzamidinhibitoren des p2x7-rezeptors |
| DE602004000260T2 (de) * | 2003-07-22 | 2006-08-24 | Arena Pharmaceuticals, Inc., San Diego | Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen |
| WO2005073193A1 (fr) * | 2004-01-23 | 2005-08-11 | Amgen Inc. | Ligands du recepteur vanilloide et leur utilisation dans des traitements |
| ATE548353T1 (de) * | 2004-03-23 | 2012-03-15 | Arena Pharm Inc | Verfahren zur herstellung von substituierte n- aryl-n'-ä3-(1h-pyrazol-5-yl)phenylü-harnstoffe and intermediate davon. |
| WO2005095391A1 (fr) * | 2004-03-24 | 2005-10-13 | Array Biopharma Inc. | Thiazoliums comme inhibiteurs de la transcetolase |
| WO2006003500A1 (fr) * | 2004-06-29 | 2006-01-12 | Pfizer Products Inc. | Procedes permettant de preparer des derives de 5-[4-(2-hydroxy-propyl)-3,5-dioxo-4,5-dihydro-3h-[1,2,4]triazin-2-yl]-benzamides par deprotection des precurseurs proteges par hydroxyle |
| MXPA06015273A (es) * | 2004-06-29 | 2007-03-15 | Pfizer Prod Inc | Procedimiento para preparar derivados de 5-[4-(2-hidroxi -etil)-3, 5-dioxo-4, 5-dihidro-3h-[1, 2, 4]-triazin -2-il]-benzamida con actividad inhibidora de p2x7 mediante reaccion del derivado no sustituido en posicion 4 de la triazina con un oxirano en |
| EP1763353A1 (fr) * | 2004-06-29 | 2007-03-21 | Warner-Lambert Company LLC | THERAPIES COMBINATOIRES DANS LESQUELLES SONT UTILISES DES INHIBITEURS DE BENZAMIDE DU RECEPTEUR P2X<SB>7</SB> |
| SA05260357B1 (ar) | 2004-11-19 | 2008-09-08 | ارينا فارماسيتو تيكالز ، أنك | مشتقات 3_فينيل_بيرازول كمعدلات لمستقبل سيروتينين 5_ht2a مفيدة في علاج الاضطرابات المتعلقه به |
| US20080015223A1 (en) * | 2004-12-03 | 2008-01-17 | Arena Pharmaceuticals, Inc. | Pyrazole Derivatives as Modulators of the 5-Ht2a Serotonin Receptor Useful for the Treatment of Disorders Related Thereto |
| US20080200530A1 (en) * | 2005-01-19 | 2008-08-21 | Unett David J | Diaryl and Arylheteroaryl Urea Derivatives as Modulators of 5-Ht2a Serotonin Receptor Useful for the Prophylaxis or Treatment of Progressive Multifocal Leukoencephalopathy |
| JP2007145814A (ja) * | 2005-10-28 | 2007-06-14 | Bizen Chemical Co Ltd | 血小板活性化因子受容体拮抗剤および組成物 |
| SG171681A1 (en) | 2006-05-18 | 2011-06-29 | Arena Pharm Inc | Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators of the 5-ht2a serotonin receptor |
| CA2646076C (fr) * | 2006-05-18 | 2015-06-30 | Arena Pharmaceuticals, Inc. | Ethers, amines secondaires et leurs derives utilises en tant que modulateurs des recepteurs 5-ht2a de la serotonine et utiles pour traiter les troubles lies a ces recepteurs |
| JP5406018B2 (ja) | 2006-05-18 | 2014-02-05 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ５−ｈｔ２ａセロトニンレセプターに関連する障害の処置に有用な５−ｈｔ２ａセロトニンレセプターのモジュレーターとしての１級アミン、およびその誘導体 |
| TWI415845B (zh) | 2006-10-03 | 2013-11-21 | Arena Pharm Inc | 用於治療與５-ｈｔ2ａ血清素受體相關聯病症之作為５-ｈｔ2ａ血清素受體之調節劑的吡唑衍生物 |
| JP5393677B2 (ja) | 2007-08-15 | 2014-01-22 | アリーナ ファーマシューティカルズ， インコーポレイテッド | ５−ＨＴ２Ａセロトニン受容体に関連した障害の治療のための５−ＨＴ２Ａセロトニン受容体のモジュレーターとしてのイミダゾ［１，２−ａ］ピリジン誘導体 |
| US20110021538A1 (en) * | 2008-04-02 | 2011-01-27 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| CA2741731A1 (fr) * | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Compositions de modulateurs du recepteur de la serotonine 5-ht2a utilespour le traitement des troubles associesaudit recepteur |
| US9126946B2 (en) | 2008-10-28 | 2015-09-08 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto |
| WO2011075596A1 (fr) | 2009-12-18 | 2011-06-23 | Arena Pharmaceuticals, Inc. | Formes cristallines de certains dérivés de 3-phényl-pyrazole, modulatrices du récepteur 5-ht2a de la sérotonine, utiles pour le traitement de troubles y étant associés |
| US9717797B2 (en) | 2013-12-05 | 2017-08-01 | International Business Machines Corporation | Polycarbonates bearing aromatic N-heterocycles for drug delivery |
| US10022355B2 (en) | 2015-06-12 | 2018-07-17 | Axovant Sciences Gmbh | Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of REM sleep behavior disorder |
| BR112018000728A2 (pt) | 2015-07-15 | 2018-09-04 | Axovant Sciences Gmbh | resumo método para a profilaxia e/ou tratamento de alucinações visuais em um sujeito com necessidade do mesmo |
| JP7163916B2 (ja) * | 2017-07-05 | 2022-11-01 | 日産化学株式会社 | ベンジル化合物 |
| EP4650002A1 (fr) * | 2024-05-15 | 2025-11-19 | Ludwig-Maximilians-Universität | Modulateurs du récepteur nucléaire tlx (nr2e1) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1986001507A1 (fr) * | 1984-08-23 | 1986-03-13 | Sandoz Ag | Sels cyclimmoniques |
| ZA86171B (en) * | 1985-01-16 | 1986-08-27 | Hoffmann La Roche | Polycyclic salts |
| EP0298466A3 (fr) * | 1987-07-10 | 1990-10-24 | F. Hoffmann-La Roche Ag | Amides substitués d'acides alcènecarboxyliques et dérivés |
| WO1989007099A1 (fr) * | 1988-02-05 | 1989-08-10 | Schering Corporation | Glycerol 2,2-disubstitue et composes analogues au glycerol, compositions et modes d'utilisation |
| EP0336142A3 (fr) * | 1988-04-04 | 1991-04-24 | American Cyanamid Company | Antagonistes pour le facteur activant de platelets |
-
1990
- 1990-05-04 US US07/519,525 patent/US5128351A/en not_active Expired - Fee Related
-
1991
- 1991-03-28 EP EP91104964A patent/EP0458037A1/fr not_active Withdrawn
- 1991-04-08 IL IL97790A patent/IL97790A0/xx unknown
- 1991-04-29 AU AU76076/91A patent/AU639325B2/en not_active Ceased
- 1991-05-01 JP JP3126518A patent/JPH061765A/ja active Pending
- 1991-05-02 CA CA002041687A patent/CA2041687A1/fr not_active Abandoned
- 1991-05-02 PT PT97538A patent/PT97538A/pt not_active Application Discontinuation
- 1991-05-02 PH PH42384A patent/PH27535A/en unknown
- 1991-05-02 PL PL29012091A patent/PL290120A1/xx unknown
- 1991-05-03 NO NO91911749A patent/NO911749L/no unknown
- 1991-05-03 KR KR1019910007218A patent/KR910019989A/ko not_active Withdrawn
- 1991-05-03 HU HU911492A patent/HUT60720A/hu unknown
- 1991-05-03 IE IE151291A patent/IE911512A1/en unknown
- 1991-05-03 ZA ZA913365A patent/ZA913365B/xx unknown
- 1991-05-03 FI FI912143A patent/FI912143A7/fi not_active Application Discontinuation
- 1991-05-04 CN CN91102966A patent/CN1056494A/zh active Pending
-
1993
- 1993-04-05 US US08/043,054 patent/US5350759A/en not_active Expired - Lifetime
-
1994
- 1994-05-24 US US08/247,954 patent/US5432189A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0458037A1 (fr) | 1991-11-27 |
| FI912143A0 (fi) | 1991-05-03 |
| CA2041687A1 (fr) | 1991-11-05 |
| AU7607691A (en) | 1991-11-07 |
| AU639325B2 (en) | 1993-07-22 |
| IE911512A1 (en) | 1991-11-06 |
| HUT60720A (en) | 1992-10-28 |
| US5350759A (en) | 1994-09-27 |
| PH27535A (en) | 1993-08-18 |
| IL97790A0 (en) | 1992-06-21 |
| FI912143L (fi) | 1991-11-05 |
| PT97538A (pt) | 1992-01-31 |
| US5128351A (en) | 1992-07-07 |
| KR910019989A (ko) | 1991-12-19 |
| ZA913365B (en) | 1992-03-25 |
| NO911749D0 (no) | 1991-05-03 |
| HU911492D0 (en) | 1991-11-28 |
| CN1056494A (zh) | 1991-11-27 |
| JPH061765A (ja) | 1994-01-11 |
| PL290120A1 (en) | 1992-12-14 |
| US5432189A (en) | 1995-07-11 |
| FI912143A7 (fi) | 1991-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO911749L (no) | Bis-arylamid og urea-antagonister for blodplateaktiverende faktor. | |
| DE69115035D1 (de) | Behälter und verschluss. | |
| IT8819179A0 (it) | Dispositivo di emodiafiltrazione erelativo procedimento di emodiafiltrazione. | |
| DE68920117D1 (de) | Plattenbehälter. | |
| DE69000467D1 (de) | Bis-aza-bicyclische anxiolytica und antidepressiva. | |
| DE3873992D1 (de) | Blutfetterniedrigende und antiatherosclerotische harnstoff-verbindungen. | |
| DE69016743D1 (de) | Vibrator. | |
| NO910544L (no) | Polymerisk fortykningsmiddel og anvendelse derav. | |
| FI893474A7 (fi) | Neutrofiler aktiverande faktor. | |
| IT8921590A0 (it) | Procedimento e dispositivo di formatura. | |
| DE69006963D1 (de) | Stark absorbierbares Arzneimittel. | |
| DE69011337D1 (de) | Polyhalodihydrodioxine und polyhalodioxole. | |
| NO890680D0 (no) | Fremgangsmaate og innretning for aa fraskille flate materialstykker. | |
| NO910955L (no) | Filtreringsjigg og anordning. | |
| NO893474L (no) | Flammehemmende midler og fremgangsmaate for anvendelse. | |
| NO903675L (no) | Aminfrie forestrede glycidyleter-addisjonsprodukter og anvendelse derav. | |
| NO890522L (no) | Substituerte imidazolinoner og imidazolinthioner. | |
| NO900271D0 (no) | Forbindelse og anvendelse. | |
| NO905221D0 (no) | Steriliseringsblandinger og anvendelse derav. | |
| ES1007687Y (es) | Estuche contenedor perfeccionado. | |
| ES1012896Y (es) | Contenedor perfeccionado. | |
| KR920008985U (ko) | 휴대용 약품 용기 | |
| ES1009053Y (es) | Envase perfeccionado. | |
| ES1015128Y (es) | Recipiente perfeccionado. | |
| ES1015691Y (es) | Contenedor perfeccionado. |